MedPage Today on MSN
Trial breathes new life into neurotrophins as target in osteoarthritis
Novel agent outperforms placebo in phase II trial, but is it enough?
By comparing osteoarthritis pain pathways known to be active in dogs and humans to those in cats with degenerative joint ...
By comparing osteoarthritis pain pathways known to be active in dogs and humans to those in cats with degenerative joint ...
By comparing osteoarthritis pain pathways known to be active in dogs and humans to those in cats with degenerative joint disease (DJD), researchers found that elevation of a particular molecule, ...
Arthritis. I remember when I was younger, I associated this word with people that were really old; and then I got it in high ...
Can-Fite Signed a Deal Worth up to $325M with the Veterinary Company VetbiolixRamat Gan, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite ...
By comparing osteoarthritis pain pathways known to be active in dogs and humans to those in cats with degenerative joint disease (DJD), researchers ...
IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...
Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), today announces the publication in The Lancet of positive results of ...
People living with osteoarthritis often have questions about their condition, but they do not always have easy access to ...
A major analysis of nearly 10,000 patients shows that simple, non-drug treatments like knee braces, hydrotherapy, and exercise can significantly ease knee osteoarthritis symptoms. These approaches not ...
Here's how to keep your knees healthy in the long haul.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results